• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随着抗凝作用增强,稀释曲线系统中“抑制作用”明显降低。这是一个与香豆素治疗患者中存在抑制剂相悖的悖论。

Apparent decrease of "inhibition" in the dilution curve system with the increase of anticoagulation. A paradox that is against the presence of inhibitors in coumarin treated patients.

作者信息

Girolami A, Fabris F, dal Bo Zanon R, Cappellato G

出版信息

Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(5):670-6.

PMID:75136
Abstract

The apparent "inhibition" found in coumarin plasma by means of the dilution curve system seems to decrease with the increase of anticoagulation. Three groups of anticoagulated patients with a P/N prothrombin time ratio of less than 1.8, between 1.8 and 2.3 and over 2.3, showed an "inhibition" of 1.6, 1.1 and 0.9 conventional units, respectively. An inverse correlation was found to exist between Thrombotest clotting times, P/N ratio, antigen/activity ratios on one side and inhibition units on the other side. These findings do not confirm the presence of "inhibitors" in coumarin treated patients.

摘要

通过稀释曲线系统在香豆素血浆中发现的明显“抑制作用”似乎随着抗凝作用的增强而降低。三组凝血酶原时间P/N比值小于1.8、在1.8至2.3之间以及大于2.3的抗凝患者,其“抑制作用”分别为1.6、1.1和0.9个传统单位。发现凝血试验凝血时间、P/N比值、抗原/活性比值与抑制单位之间存在负相关。这些发现并未证实香豆素治疗患者中存在“抑制剂”。

相似文献

1
Apparent decrease of "inhibition" in the dilution curve system with the increase of anticoagulation. A paradox that is against the presence of inhibitors in coumarin treated patients.随着抗凝作用增强,稀释曲线系统中“抑制作用”明显降低。这是一个与香豆素治疗患者中存在抑制剂相悖的悖论。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(5):670-6.
2
Factor X antigen--factor X activity discrepancy in coumarin treated patients. No relationship with dilution curve.香豆素治疗患者中凝血因子X抗原与凝血因子X活性的差异。与稀释曲线无关。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1987;114(1):126-33.
3
Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.玻璃激活诱导的凝血酶原复合物先天性凝血障碍中正常凝血酶原时间-凝血酶时间差异的降低或消失。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(2):283-93.
4
Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
Blut. 1977 Sep 29;35(3):247-52. doi: 10.1007/BF00999466.
5
Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.凝血酶原复合物先天性凝血障碍患者及香豆素治疗患者的凝血酶试验混合实验。这是反对后者存在抑制剂的又一证据。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(3):463-70.
6
Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest.在香豆素治疗患者的随访中进行的发色底物(S-2222)因子X测定。与凝血酶原时间和/或血栓试验相比无优势。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(4):610-6.
7
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.
8
Evidence against the presence of "inhibitors" in coumarin treated patients.关于香豆素治疗患者中不存在“抑制剂”的证据。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1978;105(4):523-9.
9
Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment.
Thromb Haemost. 1997 Apr;77(4):685-9.
10
Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon.凝血酶原复合物先天性凝血障碍及香豆素治疗患者中正常凝血试验与血栓形成试验的差异:一种非特异性现象。
Am J Clin Pathol. 1977 Jan;67(1):57-60. doi: 10.1093/ajcp/67.1.57.

引用本文的文献

1
Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
Blut. 1977 Sep 29;35(3):247-52. doi: 10.1007/BF00999466.